- Home
- GHRS vs EOI Comparison
GHRS vs EOI Comparison
Compare GHRS & EOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | EOI |
|---|---|---|
| Founded | 2018 | 2004 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.0M | 793.7M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | EOI |
|---|---|---|
| Price | $13.05 | $19.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $30.11 | N/A |
| AVG Volume (30 Days) | ★ 247.9K | 83.6K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.72 | $14.36 |
| 52 Week High | $20.50 | $18.88 |
Technical Indicators
Market Signals| Indicator | GHRS | EOI |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 41.11 |
| Support Level | $13.94 | $19.47 |
| Resistance Level | $15.00 | $19.79 |
| Average True Range (ATR) | 0.84 | 0.22 |
| MACD | -0.15 | 0.04 |
| Stochastic Oscillator | 3.99 | 34.21 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About EOI Eaton Vance Enhance Equity Income Fund Eaton Vance Enhanced Equity Income Fund Shares of Beneficial Interest
Eaton Vance Enhanced Equity Income Fund offers mutual funds that invest across a wide array of equity, income, and alternative strategies. The primary investment objective of the fund is to provide current income, with a secondary objective of capital appreciation.